DNA Length Polymorphism Present in the Antithrombin III Promoter Region Does not Influence Plasma Antithrombin III Activity Levels

• References

• 1 Meade TW, Dyer S, Howarth DJ, Imeson JD, Stirling Y. Antithrombin III and procoagulant activity: sex differences and effects of the menopause. Br J Haematol 1990; 74: 77-81
• 2 Tait RC, Walker ID, Davidson JF, Islam SIA, Mitchell R. Antithrombin III activity in healthy blood donors: age and sex related changes and the prevalence of asymptomatic deficiency. Br J Haematol 1990; 75: 141-142 Letter
• 3 Watanabe J, Hayashi S-I, Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the Rsal polymorphism in the 5’-flanking region. J Biochem 1994; 116: 321-326
• 4 Bock SC, Levitan DJ. Characterization of an unusual DNA length polymorphism 5’ to the human antithrombin III gene. Nucleic Acids Res 1983; 11: 8569-8582
• 5 Niessen RWLM, Rezaee F, Reitsma PH, Peters M, de Vijlder JJM, Sturk A. Ligand dependent enhancement of human antithrombin III gene expression by retinoid X receptor alpha and thyroid hormone receptor beta. In press
• 6 Winter PC, Scopes DA, Berg L-P, Millar DS, Mayne EE, Kakkar VV, Cooper DN. Investigation of the functional significance of a frequent length polymorphism in the promoter of the human antithrombin III gene. Thromb Haemost 1995; 73: 1252 Abstract